|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 272.60 SEK | -3.20% |
|
-10.09% | -14.11% |
| 06-12 | Swedish Orphan Biovitrum AB - Special Call | |
| 06-12 | Sobi presents new clinical data on hematological diseases at congress | FW |
| Capitalization | 93.63B 9.69B 8.45B 7.94B 7.22B 13.31B 841B 15.01B 36.15B 383B 36.36B 35.58B 1,412B | P/E ratio 2025 * |
20.2x | P/E ratio 2026 * | 15.1x |
|---|---|---|---|---|---|
| Enterprise value | 102B 10.52B 9.18B 8.62B 7.84B 14.45B 914B 16.3B 39.26B 416B 39.49B 38.64B 1,534B | EV / Sales 2025 * |
3.61x | EV / Sales 2026 * | 2.99x |
| Free-Float |
51.66% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Swedish Orphan Biovitrum AB
More recommendations
More press releases
| 1 day | -3.20% | ||
| 1 week | -10.09% | ||
| Current month | -7.03% | ||
| 1 month | -11.38% | ||
| 3 months | -5.08% | ||
| 6 months | -12.18% | ||
| Current year | -14.11% |
| 1 week | 271.2 |  | 291.2 |
| 1 month | 271.2 | | 312.6 |
| Current year | 241.8 | | 349.4 |
| 1 year | 241.8 | | 354.4 |
| 3 years | 197.9 | | 354.4 |
| 5 years | 127.1 | | 354.4 |
| 10 years | 89.5 | | 354.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Guido Oelkers
CEO | Chief Executive Officer | 60 | 2017-05-21 |
Henrik Stenqvist
DFI | Director of Finance/CFO | 58 | 2018-07-19 |
| Chief Tech/Sci/R&D Officer | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-05-04 | |
Staffan Schüberg
BRD | Director/Board Member | 56 | 2019-12-31 |
| Director/Board Member | 69 | 2020-12-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.15% | 240 M€ | -4.79% | - | |
| 0.9% | 4 M€ | +17.66% | - | |
| 0.48% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.20% | -10.09% | +0.52% | +29.13% | 10.08B | ||
| -1.35% | -0.89% | -18.77% | -6.75% | 76.41B | ||
| -0.50% | -0.10% | +35.00% | +20.07% | 52.15B | ||
| +1.61% | -4.34% | +13.79% | +100.83% | 33.96B | ||
| +0.01% | -4.34% | -43.41% | -37.26% | 18.54B | ||
| -0.19% | -1.88% | +109.76% | +191.64% | 16.54B | ||
| -2.03% | -5.15% | +41.50% | +719.05% | 15.41B | ||
| -0.04% | -.--% | +74.71% | +140.03% | 14.02B | ||
| -0.83% | -1.42% | +11.07% | -4.25% | 13.22B | ||
| -2.94% | -9.53% | -7.74% | -42.83% | 11.07B | ||
| Average | -0.95% | -3.04% | +21.64% | +110.96% | 26.14B | |
| Weighted average by Cap. | -0.71% | -2.20% | +13.86% | +73.60% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 28.14B 2.91B 2.54B 2.38B 2.17B 4B 253B 4.51B 10.86B 115B 10.93B 10.69B 424B | 31.64B 3.27B 2.85B 2.68B 2.44B 4.5B 284B 5.07B 12.22B 130B 12.29B 12.02B 477B |
| Net income | 4.61B 477M 416M 391M 355M 655M 41.43B 739M 1.78B 18.88B 1.79B 1.75B 69.53B | 6.1B 631M 551M 517M 470M 867M 54.85B 978M 2.36B 24.99B 2.37B 2.32B 92.03B |
| Net Debt | 8.06B 834M 728M 683M 622M 1.15B 72.47B 1.29B 3.11B 33.01B 3.13B 3.06B 122B | 941M 97.39M 84.92M 79.77M 72.55M 134M 8.46B 151M 363M 3.85B 365M 358M 14.19B |
More financial data
* Estimated data
Employees
1,895
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-19 | 272.60 kr | -3.20% | 412,364 |
| 25-06-18 | 281.60 kr | +0.36% | 419,371 |
| 25-06-17 | 280.60 kr | -2.77% | 316,574 |
| 25-06-16 | 288.60 kr | +1.26% | 378,418 |
| 25-06-13 | 285.00 kr | -2.80% | 441,716 |
Delayed Quote Nasdaq Stockholm, June 19, 2025 at 12:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
272.60SEK
Average target price
353.09SEK
Spread / Average Target
+29.53%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SOBI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition